Lipodystrophy associated with an HIV-protease inhibitor

被引：76
|
作者：
Carr, A [1 ]
Cooper, DA
机构：
[1] St Vincents Hosp, Sydney, NSW 2010, Australia
[2] Univ New S Wales, Sydney, NSW 2010, Australia
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 339卷 / 18期
关键词：
D O I：
10.1056/NEJM199810293391806
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1296 / 1296
页数：1
相关论文
共 50 条
  • [41] HIV-protease inhibitors alter retinoic acid synthesis
    Toma, E
    Devost, D
    Lan, NC
    Bhat, PV
    AIDS, 2001, 15 (15) : 1979 - 1984
  • [42] Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and below
    Verweel, Gwenda
    Burger, David M.
    Sheehan, Nancy L.
    Bergshoeff, Alina S.
    Warris, Adilia
    van der Knaap, Linda C.
    Driessen, Gertjan
    de Groot, Ronald
    Hartwig, Nico G.
    ANTIVIRAL THERAPY, 2007, 12 (04) : 453 - 458
  • [43] Evaluation of novel Saquinavir analogs for resistance mutation compatibility and potential as an HIV-Protease inhibitor drug
    Jayaswal, Amit
    Mishra, Ankita
    Mishra, Hirdyesh
    Shah, Kavita
    BIOINFORMATION, 2014, 10 (04) : 227 - 232
  • [44] Current or historic HIV-related lipodystrophy largely associated with protease inhibitor exposure is a predictor of future diabetes risk
    Mok, J.
    Goff, L.
    Peters, B.
    Duncan, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [45] Synthesis and evaluation of imidazolidinones as nonpeptide HIV-protease inhibitors
    DeLucca, GV
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (05) : 495 - 500
  • [46] HIV protease inhibitor associated nephritis.
    Martinez, F
    Beaufils, H
    Bagnis, C
    Estepa, L
    Katlama, C
    Jacobs, C
    Deray, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0608 - A0608
  • [47] Synthesis of potent and orally active HIV-protease inhibitors
    Capraro, HG
    Bold, G
    Fassler, A
    Cozens, R
    Klimkait, T
    Lazdins, J
    Poncioni, B
    Rosel, JL
    Stover, D
    Lang, M
    ARCHIV DER PHARMAZIE, 1996, 329 (06) : 273 - 278
  • [48] Pharmacokinetic interactions between HIV-protease inhibitors in rats
    Yamaji, H
    Matsumura, Y
    Yoshikawa, Y
    Takada, K
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1999, 20 (05) : 241 - 247
  • [49] Testing the HIV-protease finger-curling hypothesis
    Scott, WR
    PROTEIN SCIENCE, 2004, 13 : 196 - 196
  • [50] Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction
    Colombo, S
    Guignard, N
    Marzolini, C
    Telenti, A
    Biollaz, J
    Decosterd, LA
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 810 (01): : 25 - 34
12345